Juvenile Dermatomyositis-Clinical Phenotypes
- PMID: 31828535
- PMCID: PMC6906215
- DOI: 10.1007/s11926-019-0871-4
Juvenile Dermatomyositis-Clinical Phenotypes
Abstract
Purpose of review: Juvenile dermatomyositis is a heterogeneous disease with variable clinical outcomes. Here, we describe the recognised subtypes of idiopathic inflammatory myositis which occur in children, with particular reference to disease-associated autoantibodies.
Recent findings: Large cohort studies have demonstrated that myositis autoantibodies are common in juvenile dermatomyositis and can be found in the majority of patients. They identify homogenous clinical subgroups and inform prognosis, particularly the risks of developing interstitial lung disease. Descriptions of immune-mediated necrotising myositis in juvenile patients have highlighted a rare but important clinical subset typically associated with severe muscle disease and treatment resistance. It is increasingly apparent that autoantibodies can provide detailed information on prognosis and the likely disease associations in those with juvenile dermatomyositis. Further work is needed to establish how this knowledge should influence our approach to treatment.
Keywords: Autoantibodies; Juvenile; Myositis; Phenotype; Subgroup.
Conflict of interest statement
No potential conflicts of interest relevant to this article were reported.
Similar articles
-
Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.J Autoimmun. 2017 Nov;84:55-64. doi: 10.1016/j.jaut.2017.06.007. Epub 2017 Jun 26. J Autoimmun. 2017. PMID: 28663002 Free PMC article.
-
Serological subsets of juvenile idiopathic inflammatory myopathies--an update.Expert Rev Clin Immunol. 2016;12(4):427-37. doi: 10.1586/1744666X.2016.1131126. Epub 2016 Jan 13. Expert Rev Clin Immunol. 2016. PMID: 26651264 Review.
-
Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.Curr Rheumatol Rep. 2018 Apr 10;20(5):28. doi: 10.1007/s11926-018-0733-5. Curr Rheumatol Rep. 2018. PMID: 29637414 Review.
-
Recent research on myositis-specific autoantibodies in juvenile dermatomyositis.Zhongguo Dang Dai Er Ke Za Zhi. 2021 Oct 15;23(10):1064-1068. doi: 10.7499/j.issn.1008-8830.2106011. Zhongguo Dang Dai Er Ke Za Zhi. 2021. PMID: 34719424 Free PMC article. Review. Chinese, English.
-
Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.Autoimmun Rev. 2014 Dec;13(12):1211-9. doi: 10.1016/j.autrev.2014.08.011. Epub 2014 Aug 23. Autoimmun Rev. 2014. PMID: 25182203 Review.
Cited by
-
Deep RNA sequencing of muscle tissue reveals absence of viral signatures in dermatomyositis.Free Neuropathol. 2024 Jan 4;5:1. doi: 10.17879/freeneuropathology-2024-5149. eCollection 2024 Jan. Free Neuropathol. 2024. PMID: 38205217 Free PMC article.
-
Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial.Pediatr Rheumatol Online J. 2024 Jan 2;22(1):2. doi: 10.1186/s12969-023-00941-5. Pediatr Rheumatol Online J. 2024. PMID: 38166943 Free PMC article.
-
The Role of Myositis-Specific Autoantibodies in the Dermatomyositis Spectrum.Cureus. 2022 Mar 8;14(3):e22978. doi: 10.7759/cureus.22978. eCollection 2022 Mar. Cureus. 2022. PMID: 35415038 Free PMC article. Review.
-
Antimelanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis: clinical features and outcomes in a racially diverse patient cohort.BMC Rheumatol. 2025 Jan 9;9(1):5. doi: 10.1186/s41927-025-00455-5. BMC Rheumatol. 2025. PMID: 39789667 Free PMC article.
-
A 10-year-old girl with low-grade B cell lymphoma complicated by anti-nuclear matrix protein 2 autoantibody-positive juvenile dermatomyositis.Rheumatology (Oxford). 2022 May 30;61(6):e143-e145. doi: 10.1093/rheumatology/keab922. Rheumatology (Oxford). 2022. PMID: 34897378 Free PMC article. No abstract available.
References
-
- Symmons DP, Sills JA, Davis SM. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol. 1995;34(8):732–736. - PubMed
-
- Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, Pachman LM, NIAMS Juvenile DM Registry Physician Referral Group US incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum. 2003;49(3):300–305. - PubMed
-
- Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts) N Engl J Med. 1975;292(7):344–347. - PubMed
-
- Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts) N Engl J Med. 1975;292(8):403–407. - PubMed
-
- Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955–1964. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials